We showed that the podocyte p38MAPK pathway is activated in experimental DN, and is associated with downstream CREB phosphorylation and mesangial fibronectin accumulation [27, 28], suggesting a mechanism by which minocycline might modulate DN. The gene discussed is CREB1; the disease is liver dysplastic nodule.